ACST
ACST
Healthcare — Biotechnology
Valhalla Score
—
A proprietary composite score from 0–100 measuring a stock's technical strength, sector-relative performance, and institutional flow activity. Higher scores indicate stronger setups.
—
—
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
📊 Key Statistics
Market Cap—
P/E Ratio—
EPS (TTM)—
EPS YoY—
Revenue YoY—
Float—
Short Float %—
Inst. Ownership—
Sector RS—
📈 Fundamentals
ROE—
ROIC—
ROA—
Current Ratio—
Debt/Equity—
Gross Margin—
Net Margin—
Dividend Yield—
Next Earnings—
⚡ Options Summary
Call OI—
Put OI—
P/C Ratio (OI)—
Gamma Environment—
Max Pain—
Call Wall—
Put Wall—
🎯 Analyst Estimates
Consensus Target—
High Target—
Low Target—
Analysts—
Upside/Downside—
📋 Quarterly Financials
| Period | Revenue | Rev YoY | EPS | EPS YoY | Gross Margin |
|---|
🔥 Recent Options Flow
| Type | Strike | Exp | Size | Premium | Time |
|---|
🏛️ Institutional Trades
| Type | Price | Size | Value | Venue | Time |
|---|
👤 Insider Trades
| Name | Type | Shares | Price | Date |
|---|
🏦 Top Institutional Holders
| Institution | Shares | Value | % of Class |
|---|